首页> 外文期刊>International ophthalmology >Glaucoma therapy escalation in eyes with pseudophakic corneal edema after penetrating keratoplasty and Descemet's stripping automated endothelial keratoplasty
【24h】

Glaucoma therapy escalation in eyes with pseudophakic corneal edema after penetrating keratoplasty and Descemet's stripping automated endothelial keratoplasty

机译:穿透性角膜移植和Descemet剥离自动角膜内皮移植术后假晶状体眼角膜水肿的青光眼治疗升级

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to determine and compare the prevalence of glaucoma therapy escalation (GTE) after penetrating keratoplasty (PKP) and Descemet's stripping automated endothelial keratoplasty (DSAEK) in eyes with a surgical indication of pseudophakic corneal edema. A retrospective review was conducted of the medical records of all patients who underwent PKP or DSAEK to treat pseudophakic corneal edema at a tertiary eye care center from January 1 2003 to December 31, 2006. Eyes that were treated with PKP from January 1, 2003 to December 31, 2004 and with DSAEK from January 1, 2005 to December 31, 2006 were included in the statistical analysis. Inclusion criteria included satisfactory preoperative control of intraocular pressure (IOP) and follow-up of at least 12 months. The main outcome measure was GTE, which was defined as a sustained requirement for escalation of topical medical therapy or the need to provide surgical intervention to maintain a satisfactory postoperative IOP. Among 54 eyes that met the inclusion criteria, GTE occurred in 7 (35.0%) of 20 eyes after PKP and in 14 (41.2%) of 34 eyes after DSAEK (P = 0.78) during a mean follow-up period of 27.6 and 28.6 months, respectively. Surgical escalation occurred in 2 (10.0%) eyes after PKP and 2 (5.9%) eyes after DSAEK (P = 0.62), and was associated with late-onset endothelial graft failure in all four eyes. Glaucoma therapy escalation is relatively common and occurs with comparable frequency in eyes with pseudophakic corneal edema after PKP and DSAEK.
机译:这项研究的目的是确定和比较穿透性角膜移植术(PKP)和Descemet剥离自动内皮细胞角膜移植术(DSAEK)在具有假晶状角膜水肿手术指征的眼睛中的青光眼治疗升级(GTE)的患病率。回顾性回顾了2003年1月1日至2006年12月31日在三级眼保健中心接受过PKP或DSAEK治疗假晶状体角膜水肿的所有患者的病历。2003年1月1日至2006年12月31日用PKP治疗的眼睛统计分析包括2004年12月31日以及2005年1月1日至2006年12月31日与DSAEK的合作。纳入标准包括术前对眼内压(IOP)的满意控制以及至少12个月的随访。主要结局指标是GTE,它被定义为局部药物治疗升级的持续需求或提供手术干预以维持令人满意的术后IOP的需求。在符合纳入标准的54眼中,在平均随访期27.6和28.6中,PKP后20眼中有7眼(35.0%)发生了GTE,DSAEK后34眼中有14眼(41.2%)发生了GTE(P = 0.78)。个月。外科手术升级发生在PKP术后2眼(10.0%)和DSAEK术后2眼(5.9%)(P = 0.62),并且与所有四眼的迟发性内皮移植失败有关。青光眼治疗升级是相对常见的,在PKP和DSAEK后出现假晶状体角膜水肿的眼睛中发生频率相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号